Centrica


Target price down by 4.3%

30/03/21 -"Following the disappointing set of figures published by Centrica, we decrease our target price by 4.3% as a result of lower EPS for FY21 and FY22, and a lower NAV. Globally, we maintain our cautious ..."

Pages
49
Language
English
Published on
30/03/21
You may also be interested by these reports :
13/04/21
EPS for FY20 is lower than expected as a result of a disappointing set of figures between EBITDA and EBIT: D&A and impairments are both higher than ...

12/04/21
Suez and Veolia have announced an agreement in principle on the key terms of their merger. The deal price is €20.5 per share, i.e. 13.9% higher than ...

12/04/21
Suez and Veolia have announced an agreement in principle on the key terms of their merger. The deal price is €20.5 per share, i.e. 13.9% higher than ...

09/04/21
We have changed our opinion from Add to Reduce and lowered our target price by 12.1% to €4.59 as the group’s strategy, focused on hydrogen, is a ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO